Sientra halts medical implant sales

Sientra halts medical implant sales, Breast implant maker Sientra Inc said it has placed a acting authority on sales of medical implants fabricated by a Brazilian arrangement manufacturer, sending its shares down 11 percent in continued trading.

Sientra aswell said it recommends that artificial surgeons briefly abandon implanting all Sientra accessories fabricated by the Brazilian contractor, Silimed, until added notice.

Sientra said its accommodation followed discussions with the U.S. Food and Drug Administration apropos Brazilian authoritative inquiries into articles bogus by Silimed. Sientra said it is aswell administering its own review.

The Brazilian bloom regulator on Monday abeyant the accomplishment of all medical accessories fabricated by Silimed. Sientra said Brazilian regulators accept been reviewing abstruse acquiescence issues at Silimed's accomplishment facility.

Sientra, based in Santa Barbara, California, said Brazilian and added regulators accept not had any letters of adverse contest or begin any risks to accommodating bloom from the devices.

Sientra shares accept collapsed about 32 percent back Monday. The shares bankrupt at $7.01 on the Nasdaq on Friday.

Share on Google Plus

About JULIA

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.